Finance

Beta
Ask
Lists
300497:SHE
Jiangxi Fushine Pharmaceutical Co Ltd
CN¥15.25
-2.18%
(-0.34) 1D
Jun 11, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300497...
Open
CN¥15.40
High
CN¥15.71
Low
CN¥15.13
Mkt. cap
8.40B
Avg. vol.
34.71M
Volume
17.96M
P/E ratio
9,186.75
52-wk high
CN¥22.63
52-wk low
CN¥8.60
EPS
CN¥0.00
Shares outstanding
538.65M
No. of employees
2K
Open
CN¥15.40
High
CN¥15.71
Low
CN¥15.13
Mkt. cap
8.40B
Avg. vol.
34.71M
Volume
17.96M
P/E ratio
9,186.75
52-wk high
CN¥22.63
52-wk low
CN¥8.60
EPS
CN¥0.00
Shares outstanding
538.65M
No. of employees
2K
News stories
From sources across the web
About Jiangxi Fushine Pharmaceutical Co Ltd
CEO-
Employees1.66K
FoundedMar 20, 2002
Headquarters-
SectorPharmaceutical industry
Websitefushine.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
280.98M
254.68M
415.64M
357.76M
Cost of goods sold
230.99M
247.32M
318.51M
220.70M
Cost of revenue
230.99M
247.32M
318.51M
220.70M
Research and development expenses
15.86M
14.18M
15.40M
12.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.96M
36.98M
49.14M
36.10M
Operating expense
61.78M
21.00M
107.93M
58.20M
Total operating expenses
292.77M
268.31M
426.44M
278.89M
Operating income
-11.80M
-13.64M
-10.80M
78.87M
Other non operating income
2.72M
-3.94M
5.39M
-5.89M
EBT including unusual items
-10.53M
-58.83M
-3.56M
59.20M
EBT excluding unusual items
-16.73M
-26.33M
-24.11M
61.52M
Income tax expense
73.31K
-1.14M
-8.28M
-263.12K
Effective tax rate
-0.70%
1.93%
232.34%
-0.44%
Other operating expenses
3.10M
-27.78M
34.37M
4.09M
Net income
-9.15M
-55.84M
7.73M
61.20M
Net profit margin
-3.26%
-21.93%
1.86%
17.11%
Earnings per share
-
-
-
-
Interest and investment income
1.71M
1.33M
997.56K
764.06K
Interest expense
-9.54M
-9.91M
-16.38M
-12.22M
Net interest expenses
-7.82M
-8.57M
-15.38M
-11.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
35.27M
29.04M
35.99M
125.66M
Gain or loss from assets sale
-13.58K
13.58K
377.06K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more